Term spontaneous trial of labor in nulliparous women of short stature: A hospitals-based cohort study.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 06 12 2019
revised: 10 01 2020
accepted: 11 01 2020
pubmed: 3 2 2020
medline: 15 12 2020
entrez: 3 2 2020
Statut: ppublish

Résumé

To study the mode of delivery in a well selected cohort of short nulliparous women. Hospitals-based cohort study between 2010-2018. The threshold (150 cm, i.e 2,3°p), for the short stature was chosen before the analysis by corresponding to - 2SD of the average population size distribution of all women who delivered over the same period: 2010-2018. Were included nulliparous women with a heigh ≤ 150 cm in term spontaneous labor with a single livung fetus in vertex presentation without malformation. Exclusion criteria were: multiparous, scarred uterus, twin pregnancy, induced labor, preterm delivery (< 37 W P), non-vertex pregnancy, medical termination of pregnancy, stillbirth, severe fetal malformations, pre-labor cesarean, and late dating ultrasound. The main outcome was the mode of delivery. Univariate and multivariate analysis adjusted on potential confounding variable were performed to investigate the risk of intrapartum CS. 178 nulliparous women were included. The mean height was 148 cm. The rate of spontaneous vaginal delivery, operative vaginal delivery a nd intrapartum CS were :35,4 %, 35,4 % and 29,2 % respectively. Intrapartum CS was performed during the first stage labor in 15 (28, 8 %) women and during the second stage in 37 (71, 2 %) women. An arrest of labor was significantly more frequent in the active labor than the early labor stage: 62,1 % vs. 33.3 % (p = 0, 02). In univarate analysis were associated with intrapartum CS : Gestational diabetes, birthweight> 3,5 kg, individual adjusted birthweight >90°p, occiput posterior, oxytocin use, cephalic circumference. After adjustment on birthplace and overweight (BMI over 25), only a birthweight > 3,5 kg remains associated with the risk of intrapartum CS (aOR4.3 ;95 %CI 1.96-10.2). An attempt of vaginal birth is a reasonable option for short stature women. Maternal height could be included in the selection criteria for planned birth center or home birth. The customized gestational-related optimal weigh could be useful to identify large of gestational age fetus.

Identifiants

pubmed: 32007340
pii: S0301-2115(20)30020-8
doi: 10.1016/j.ejogrb.2020.01.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-186

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jérémy Boujenah (J)

Department of Obstetrics, Gynaecology Bondy, France Assistance Publique-Hôpitaux de Paris, Paris, France; Medical University Department of North Paris France. Electronic address: Jeremy.boujenah@gmail.com.

Lionel Carbillon (L)

Department of Obstetrics, Gynaecology Bondy, France Assistance Publique-Hôpitaux de Paris, Paris, France; Medical University Department of North Paris France.

Pauline Banh (P)

Department of Obstetrics, Gynaecology Bondy, France Assistance Publique-Hôpitaux de Paris, Paris, France; Medical University Department of North Paris France.

Olivier Sibony (O)

Department of Obstetrics, Gynaecology Robert Debré, France Assistance Publique-Hôpitaux de Paris, Paris, France; Medical University Department of North Paris France.

Diane Korb (D)

Department of Obstetrics, Gynaecology Robert Debré, France Assistance Publique-Hôpitaux de Paris, Paris, France; Medical University Department of North Paris France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH